AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,594,098 | -31.4% | 110,599 | -36.6% | 0.00% | 0.0% |
| Q2 2023 | $8,149,739 | -59.0% | 174,550 | -66.4% | 0.00% | -63.6% |
| Q1 2023 | $19,878,940 | -15.2% | 519,575 | +21.5% | 0.01% | -15.4% |
| Q4 2022 | $23,437,028 | +5312.7% | 427,683 | +3260.7% | 0.01% | – |
| Q3 2022 | $433,000 | +211.5% | 12,726 | -13.8% | 0.00% | – |
| Q2 2022 | $139,000 | -40.6% | 14,763 | -10.7% | 0.00% | – |
| Q1 2022 | $234,000 | -39.1% | 16,531 | -9.0% | 0.00% | – |
| Q4 2021 | $384,000 | -53.5% | 18,171 | -50.8% | 0.00% | – |
| Q3 2021 | $826,000 | -12.5% | 36,967 | -2.8% | 0.00% | – |
| Q2 2021 | $944,000 | +8.0% | 38,045 | +26.3% | 0.00% | – |
| Q1 2021 | $874,000 | -48.7% | 30,129 | -54.4% | 0.00% | -100.0% |
| Q4 2020 | $1,704,000 | -53.9% | 66,055 | -45.0% | 0.00% | -66.7% |
| Q3 2020 | $3,695,000 | +161.5% | 119,991 | +111.6% | 0.00% | +200.0% |
| Q2 2020 | $1,413,000 | +2378.9% | 56,714 | +1996.6% | 0.00% | – |
| Q1 2020 | $57,000 | +54.1% | 2,705 | +60.0% | 0.00% | – |
| Q4 2019 | $37,000 | +27.6% | 1,691 | +28.4% | 0.00% | – |
| Q3 2019 | $29,000 | – | 1,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |